The Collaborative Crisis: How Pharma Can Shake Up Its Silos

By Tony Fross and Jeff Gourdji

Pharma has a significant collaboration challenge. Some companies manage external partnerships when they must — they know they can’t produce consistent growth from their pipelines. But when it comes to internal collaboration, they struggle. The production of the COVID-19 vaccine, developed at light speed through external partnerships, is the exception that proves the rule.